الفهرس 
Utilization of a nanocarrier as a feasible tool for liver targeting of a certain drug
Table of ContentsOnly 14 pages are availabe for public view
 |  | from | 239 |  |  |
| | | from | 239 | | |
Abstract
Gallic acid (GA) is characterized by its protective properties towards induced apoptosis in tumor cells, carbon tetrachloride induced liver injury and lung fibroblasts. It has the ability to hinder the proliferation of activated hepatic stellate cells (aHSCs) and control progression of liver fibrosis. However, the hydrophilic properties of GA hindered its entrapment in different vesicles formulations due to its fast partitioning with the surrounding aqueous media. Moreover, GA is poorly absorbed and rapidly metabolized leading to faster elimination and shorter peak plasma concentration and hence, diminished bioavailability. The present study aims to encapsulate GA into different nanocarrier systems for the passive and active targeting of GA to aHSCs for the effective treatment of liver fibrosis